SBIR Phase II: Microchip Assay for Glycosylated Hemoglobin

SBIR 第二阶段：糖基化血红蛋白的微芯片测定

• 批准号: 0548744
• 负责人: Dale Willard
• 金额: --
• 依托单位: Advanced MicroLabs, LLC
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-03-01 至 2008-10-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0548744&HistoricalAwards=false
• 关键词: SBIR; Phase; II; Microchip; Assay

This Small Business Innovation Research (SBIR) Phase II project aims at developing the next generation of diabetic monitoring devices that will allow the measurement of multiple markers of disease regulation and progression using an innovative lab-on-a-chip technology. The project will develop the first integrated microchip CE device for measurement of an important maker of diabetes.This technology will impact patient monitoring for disease progression and therapeutic efficacy by following biomarker more efficiently as well as being used at the point of care. This eliminates the time and cost currently required to perform follow up laboratory tests. The technology approaches the chemistry of biomarkers from a non-traditional sensor mechanism and shows great promise for the detection and use of biomarkers for specific diseases.

该小型企业创新研究（SBIR）第二阶段项目旨在开发下一代糖尿病监测设备，该设备将允许使用创新的芯片实验室技术测量疾病调节和进展的多个标志物。该项目将开发第一个集成微芯片CE设备，用于测量糖尿病的重要制造商。该技术将通过更有效地跟踪生物标志物以及在护理点使用来影响患者对疾病进展和治疗效果的监测。这消除了目前进行后续实验室测试所需的时间和成本。该技术从非传统的传感器机制接近生物标志物的化学，并显示出检测和使用特定疾病的生物标志物的巨大前景。